Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Oct 2;20(5):1019–1028.e3. doi: 10.1016/j.cgh.2021.09.029

Figure 2.

Figure 2.

Ex-vivo assessments. Comparison of transmucosal resistance (TMR) (A), basal Isc (B), and rate of FITC–dextran flux measured over 3 hours (C) between controls and FD. Correlation between baseline duodenal transmucosal resistance (TMR) and FITC-dextran flux (D).